171 related articles for article (PubMed ID: 35139778)
1. Molecular Signaling Pathways as Potential Therapeutic Targets in Osteosarcoma.
Dana PM; Sadoughi F; Asemi Z; Yousefi B
Curr Med Chem; 2022; 29(25):4436-4444. PubMed ID: 35139778
[TBL] [Abstract][Full Text] [Related]
2. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
3. Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma.
Shaikh AB; Li F; Li M; He B; He X; Chen G; Guo B; Li D; Jiang F; Dang L; Zheng S; Liang C; Liu J; Lu C; Liu B; Lu J; Wang L; Lu A; Zhang G
Int J Mol Sci; 2016 Apr; 17(4):506. PubMed ID: 27058531
[TBL] [Abstract][Full Text] [Related]
4. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
[TBL] [Abstract][Full Text] [Related]
5. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
Liu B; Xu L; Dai EN; Tian JX; Li JM
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
[TBL] [Abstract][Full Text] [Related]
7. PI3K/Akt signaling in osteosarcoma.
Zhang J; Yu XH; Yan YG; Wang C; Wang WJ
Clin Chim Acta; 2015 Apr; 444():182-92. PubMed ID: 25704303
[TBL] [Abstract][Full Text] [Related]
8. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
[TBL] [Abstract][Full Text] [Related]
10. PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells.
Xi Y; Qi Z; Ma J; Chen Y
Clin Exp Metastasis; 2020 Feb; 37(1):173-185. PubMed ID: 31571016
[TBL] [Abstract][Full Text] [Related]
11. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
[TBL] [Abstract][Full Text] [Related]
12. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity.
Soghli N; Ferns GA; Sadeghsoltani F; Qujeq D; Yousefi T; Vaghari-Tabari M
Biochem Pharmacol; 2022 Jul; 201():115094. PubMed ID: 35588853
[TBL] [Abstract][Full Text] [Related]
14. Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment.
Fioramonti M; Fausti V; Pantano F; Iuliani M; Ribelli G; Lotti F; Pignochino Y; Grignani G; Santini D; Tonini G; Vincenzi B
Sci Rep; 2018 Mar; 8(1):4177. PubMed ID: 29520051
[TBL] [Abstract][Full Text] [Related]
15. Advanced development of ErbB family-targeted therapies in osteosarcoma treatment.
Wang W; Zhao HF; Yao TF; Gong H
Invest New Drugs; 2019 Feb; 37(1):175-183. PubMed ID: 30353245
[TBL] [Abstract][Full Text] [Related]
16. Schisandrin B suppresses osteosarcoma lung metastasis
Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
[TBL] [Abstract][Full Text] [Related]
17. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
[TBL] [Abstract][Full Text] [Related]
18. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
20. Research progress in the mechanism and treatment of osteosarcoma.
Bian J; Liu Y; Zhao X; Meng C; Zhang Y; Duan Y; Wang G
Chin Med J (Engl); 2023 Oct; 136(20):2412-2420. PubMed ID: 37649421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
